Changes in GAD67 mRNA expression evidenced by in situ hybridization in the brain of R6/2 transgenic mice

Journal of Neurochemistry

Volumn 86, Issue 6, 2003, Pages 1369-1378

  Gourfinkel An, I ^a   Parain, K ^a   Hartmann, A ^a   Mangiarini, L ^b   Brice, A ^a   Bates, G ^b   Hirsch, E C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cortex; GABA; Huntington; Polyglutamine; Striatum

Indexed keywords

ADENINE; CYTOSINE; DNA BASE; GLUTAMATE DECARBOXYLASE; GUANINE; MESSENGER RNA; GLUTAMATE DECARBOXYLASE 67; ISOENZYME;

ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BEHAVIOR; BRAIN DEGENERATION; CEREBELLUM; CONTROLLED STUDY; DISEASE MODEL; EXON; GABAERGIC SYSTEM; HUNTINGTON CHOREA; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; NUCLEOTIDE REPEAT; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPTUM PELLUCIDUM; STRIATE CORTEX; TRANSGENIC MOUSE; ANIMAL; BRAIN; DISEASE COURSE; GENETICS; HUMAN; METABOLISM; PARASITOLOGY; TRINUCLEOTIDE REPEAT;

ANIMALIA; EUKARYOTA; MUS MUSCULUS;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GLUTAMATE DECARBOXYLASE; HUMANS; HUNTINGTON DISEASE; IN SITU HYBRIDIZATION; ISOENZYMES; MICE; MICE, TRANSGENIC; RNA, MESSENGER; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 0141432169     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01916.x     Document Type: Article

References (54)

1. Andrew S. E., Goldberg Y. P., Kremer B., Telenius H., Theilmann J., Adam S., Starr E., Squitieri F., Lin B., Kalchman M. A. et al. (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat. Genet. 4, 398-403.
2. Baran H., Lassman H. and Homykiewicz O. (1988) Behavioural and neurochemical changes 6 months after kainic acid. Soc. Neurosci. 14, 1972 (abstract).
3. Barbeau A., Duvoisin R. C., Gerstenbrand F., Lakke J. P., Marsden C. D. and Stern G. (1981) Classification of extra pyramidal disorders. Proposal for an international classification and glossary of terms. J Neurol. Sci. 51, 311-327.
4. Bird E. D. and Iversen L. L. (1974) Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain 97, 457-472.
5. Brackenridge C. J. (1980) Factors influencing dementia and epilepsy in Huntington's disease of early onset. Acta Neurol. Scand. 62, 305-311.
6. Bu D. F., Erlander M. G., Hitz B. C., Tillakaratne N. J., Kaufman D. L., Wagner-McPherson C. B., Evans G. A. and Tobin A. J. (1992) Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc. Natl Acad. Sci. USA 89, 2115-2119.
7. Carter R. J., Lione L. A., Humby T., Mangiarini L., Mahal A., Bates G. P., Dunnett S. B. and Morton A. J. (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 19, 3248-3257.
8. Cepeda C., Ariano M. A., Calvert C. R., Flores-Hernandez J., Chandler S. H., Leavitt B. R., Hayden M. R. and Levine M. S. (2001) NMDA receptor function in mouse models of Huntington disease. J. Neurosci. Res. 66, 525-539.
9. Cha J. H., Kosinski C. M., Kerner J. A., Alsdorf S. A., Mangiarini L., Davies S. W., Penney J. B., Bates G. P. and Young A. B. (1998) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene. Proc. Natl Acad. Sci. USA 95, 6480-6485.
10. Chesselet M. F., Weiss L., Wuenschell C., Tobin A. J. and Affolter H. U. (1987) Comparative distribution of mRNAs for glutamic acid decarboxylase, tyrosine hydroxylase, and tachykinins in the basal ganglia: an in situ hybridization study in the rodent brain. J. Comp. Neurol. 262, 125-140.
11. Davies S. W., Turmaine M., Cozens B. A., DiFiglia M., Sharp A. H., Ross C. A., Scherzinger E., Wanker E. E., Mangiarini L. and Bates G. P. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548.
12. Davies S. W., Beardsall K., Turmaine M., DiFiglia M., Aronin N. and Bates G. P. (1998) Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions? Lancet 351, 131-133.
13. Di Figlia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J. P. and Aronin N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.
14. Fahn S. (1988) Concept and classification of dystonia. Adv. Neurol. 50, 1-8.
15. Ferrante R. J., Kowall N. W., Beal M. F., Martin J. B., Bird E. D. and Richardson E. P. Jr (1987) Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J. Neuropathol. Exp. Neurol. 46, 12-27.
16. Filion M. and Tremblay L. (1991) Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res. 547, 142-151.
17. Fontaine B., Sassoon D., Buckingham M., Changeux J.P. (1988) Detection of the nicotinic acetylcholine receptor subunit mRNA by in situ hybridization at neuromuscular junction of 15-day-old chick striatal muscles. E. M. B. O. J. 7, 603-609.
18. Gale K. and Casu M. (1981) Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications. Mol. Cell. Biochem. 39, 369-405.
19. Graybiel A. M. and Ragsdale C. W. Jr (1978) Histochemically distinct compartments in the striatum of human, monkey, and cat demonstrated by acetylthiocholinesterase staining. Proc. Natl Acad. Sci. USA 75, 5723-5726.
20. Herrero M. T., Ruberg M., Hirsch E. C., Mouatt A., Tobin A. J., Agid Y., Obeso J. A. and Javoy-Agid F. (1993) In situ hybridization of GAD mRNA in monkey and human brain: quantification at both regional and cellular levels. Neurosci. Lett. 157, 57-61.
21. Herrero M. T., Levy R., Ruberg M., Luquin M. R., Villares J., Guillen J., Faucheux B., Javoy-Agid F., Guridi J., Agid Y. et al. (1996) Consequence of nigrostriatal denervation and 1-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum. Neurology 47, 219-224.
22. Hickey M. A., Reynolds G. P. and Morton A. J. (2002) The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease. J. Neurochem. 81, 46-59.
23. Hockly E., Cordery P. M., Woodman B., Mahal A., van Dellen A., Blakemore C., Lewis C. M., Hannan A. J. and Bates G. P. (2002) Environmental enrichment slows disease progression in R6/2 Huntington's disease mice. Ann. Neurol. 51, 235-242.
24. Javoy-Agid F., Hirsch E. C., Dumas S., Duyckaerts C., Mallet J. and Agid Y. (1990) Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study. Neuroscience 38, 245-253.
25. Kaufman D. L., Houser C. R. and Tobin A. J. (1991) Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J. Neurochem. 56, 720-723.
26. Lakke P. W. F. (1981) Classification of extrapyramidal disorders. Proposal for an international classification and glossary of terms. J. Neurol. Sci. 51, 213-327.
27. Levy R., Herrero M. T., Ruberg M., Villares J., Faucheux B., Guridi J., Guillen J., Luquin M. R., Javoy-Agid F., Obeso J. A. et al. (1995) Effects of nigrostriatal denervation and 1-dopa therapy on the GABAergic neurons in the striatum in MPTP-treated monkeys and Parkinson's disease: an in situ hybridization study of GAD67 mRNA. Eur. J. Neurosci. 7, 1199-1209.
28. Lievens J. C., Woodman B., Mahal A., Spasic-Boscovic O., Samuel D., Kerkerian-Le Goff L. and Bates G. P. (2001) Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol. Dis. 8, 807-821.
29. Lindefors N., Brene S. and Persson H. (1990) Increased expression of glutamic acid decarboxylase mRNA in rat substantia nigra after an ibotenic acid lesion in the caudate-putamen. Mol. Brain Res. 7, 207-212.
30. Luthi-Carter R., Strand A. D., Hanson S. A., Kooperberg C., Schilling G., La Spada A. R., Merry D. E., Young A. B., Ross C. A., Borchelt D. R. et al. (2002) Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects. Hum. Mol. Genet. 11, 1927-1937.
31. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S. W. et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506.
32. Mann D. M., Oliver R. and Snowden J. S. (1993) The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathol. 85, 553-559.
33. Markham C. H. and Knox J. W. (1965) Observations of Huntington's chorea in childhood. J. Pediatr. 67, 446-457.
34. Marksteiner J. and Sperk G. (1988) Concomitant increase of somatostatin, neuropeptide Y and glutamate decarboxylase in the frontal cortex of rats with decreased seizure threshold. Neuroscience 26, 379-385.
35. Martin D. L. and Rimvall K. (1993) Regulation of gamma-aminobutyric acid synthesis in the brain. J. Neurochem. 60, 395-407.
36. Martin D. L., Martin S. B., Wu S. J. and Espina N. (1991) Cofactor interactions and the regulation of glutamate decarboxylase activity. Neurochem. Res. 16, 243-249.
37. Martin J. B. (1984) Huntington's disease: new approaches to an old problem. Neurology 34, 1059-1072.
38. Martin J. B. and Gusella J. F. (1986) Huntington's disease. Pathogenesis and management. N. Engl. J. Med. 315, 1267-1276.
39. Meade C. A., Deng Y. P., Fusco F. R., Del Mar. N., Hersch S., Goldowitz D. and Reiner A. (2002) Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice. J. Comp. Neurol. 449, 241-269.
40. Menalled L. B. and Chesselet M.-F. (2002) Mouse models of Huntington's disease. Trends Pharmacol. Sci. 23, 32-39.
41. Miller W. C. and DeLong M. R. (1987) Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism, in The Basal Ganglia II (Carpenter M. B. and Sayaraman A., eds), pp. 415-427. Plenum, New York.
42. Murphy K. P., Carter R. J., Lione L. A., Mangiarini L., Mahal A., Bates G. P., Dunnett S. B. and Morton A. J. (2000) Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. J. Neurosci. 20, 5115-5123.
43. Reynolds G. P., Dalton C. F., Tillery C. L., Mangiarini L., Davies S. W. and Bates G. P. (1999) Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation. J. Neurochem. 72, 1773-1776.
44. Roizin L., Stellar S. and Liu J. C. (1979) Neuronal nuclear and cytoplasmic changes in Huntington's chorea: electron microscope investigations, in Advances in Neurology (Chase T. N., Wexler N. S., Barbeau A., eds), pp. 95-122. Raven Press, New York.
45. Salin P. and Chesselet M. F. (1993) Expression of GAD (M(r) 67,000) and its messenger RNA in basal ganglia and cerebral cortex after ischemic cortical lesions in rats. Exp. Neurol. 119, 291-301.
46. Sathasivam K., Amaechi I., Mangiarini L. and Bates G. (1997) Identification of an HD patient with a (CAG) 180 repeat expansion and the propagation of highly expanded CAG repeats in lambda phage. Hum. Genet. 99, 692-695.
47. Saudou F., Finkbeiner S., Devys D. and Greenberg M. E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66.
48. Szabo G., Katarova Z., Kortvely E., Greenspan R. J. and Urban Z. (1996) Structure and the promoter region of the mouse gene encoding the 67-kD form of glutamic acid decarboxylase. DNA Cell Biol. 15, 1081-1091.
49. Szot P., Leverenz J. B., Peskind E. R., Kiyasu E., Rohde K., Miller M. A. and Raskind M. A. (2000) Tyrosine hydroxylase and norepinephrine transporter mRNA expression in the locus coeruleus in Alzheimer's disease. Mol. Brain Res. 84, 135-140.
50. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable in Huntington's disease. Cell 73, 971-983.
51. Turmaine M., Raza A., Mahal A., Mangiarini L., Bates G. P. and Davies S. W. (2000) Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc. Natl Acad. Sci. USA 97, 8093-8097.
52. Vila M., Herrero M. T., Levy R., Faucheux B., Ruberg M., Guillen J., Luquin M. R., Guridi J., Javoy-Agid F., Agid Y. et al. (1996) Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes. Neurology 46, 802-809.
53. Vonsattel J. P., Myers R. H., Stevens T. J., Ferrante R. J., Bird E. D. and Richardson E. P. Jr (1985) Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559-577.
54. Wood T. L., Frantz G. D., Menkes J. H. and Tobin A. J. (1986) Regional distribution of messenger RNAs in postmortem human brain. J. Neurosci. Res. 16, 311-324.